Screener Summaries Updates Institutions Sign In More Updates › Financing › INDP Financing · Sep 30, 2026
Extends closing of $24M private placement to October 16 INDP Indaptus Therapeutics, Inc.
Indaptus Therapeutics extended the outside date for its previously announced $24.0 million private placement of common stock from September 29, 2026, to October 16, 2026. The company and purchasers agreed to defer and coordinate the closing until conditions are satisfied or waived. Indaptus Therapeutics operates in the biotechnology industry.
More from Indaptus Therapeutics, Inc. Indaptus Therapeutics completes $24M private placement of over 20.3M shares Oct 20, 2026 On September 8, 2026, Indaptus Therapeutics, Inc. entered into a Stock Purchase Agreement to issue and sell 20,338,974… Sep 9, 2026 Indaptus Therapeutics, Inc. entered into an Amended and Restated At the Market Offering Agreement with H.C. Wainwright… Sep 4, 2026 On September 2, 2026, Tim Ruan resigned from the Board of Directors of Indaptus Therapeutics, Inc., effective… Sep 4, 2026 Indaptus Therapeutics, Inc. entered into an Amended and Restated At the Market Offering Agreement with H.C. Wainwright… Sep 1, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
